Navigation Links
Unique Glaucoma Test Through Eyelid DIATON Opens Doctors' Eyes to Possibility of In-Office Glaucoma Test at Pri-Med East and American Academy of Family Physicians, AAFP
Date:9/20/2013

challenge Glaucoma, a 'silent thief of sight,' that carries an ever increasing threat of causing blindness as the aging population is growing in the U.S. and abroad," said Roman Iospa, CEO of BiCOM Inc.

Diaton Tonometer is intended for use by Inpatient & Outpatient Clinics such as Hospitals, Emergency Rooms, Nursing & Elderly Homes, General & Specialty Practitioners as well as Ophthalmologists and Optometrists.

More details about Diaton tonometer pen - Glaucoma IOP Eye Test can be found at http://www.GlaucomaEyeTest.com or via phone 1-877-DIATONS (342-8667).

Visit us at Pri-Med East Booth #601 and AAFP Booth #2921

ABOUT BICOM INC:

BiCOM Inc. is committed to the global fight against blindness caused by glaucoma. A unique team of engineers, medical and business experts makes BiCOM Inc. uniquely placed to provide DIATON diagnostic tonometer pen, which measures intraocular pressure (IOP) through the eyelid and sclera, making it possible to diagnose glaucoma in the early stage and appoint necessary treatment and medicines and provide a much more favorable outcome for the patient. More about DIATON Tonometer Glaucoma IOP Eye Test at http://www.GlaucomaEyeTest.com or call BiCOM at the toll free number 1-877-diatons (1-877-342-8667).

Media Contact: Alina Lagoviyer, Media / Public Relations, 1-877-342-8667 ext 777

BiCOM Inc., 151 East Walnut Street, Long Beach, NY 11561 http://www.TonometerDiaton.com

Follow Diaton tonometer on: http://www.Facebook.com/tonometer http://www.Twitter.com/tonometer  

SOURCE BiCOM, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aptel Research Launches Unique Patient-centric Syndicated Report Series That Analyze the Patient Journey for Chronic Diseases in Specialty Markets
2. JHP Pharmaceuticals Enters Agreement to Produce Unique Late Stage Ophthalmic Product
3. BGI Tech and South Texas Accelerated Research Therapeutics Initiate Collaboration to Advance Unique San Antonio 1000 Cancer Genome Project
4. Unique New PIR Knee System Receives CE Mark
5. Pharmaceutical Giants Back Researchers in Unique US Competition
6. New Study Shows Unique Dietary Supplement With Omega Fatty Acids Holds Promise For 30 Million Americans Who Suffer From Dry Eye
7. ErtelAlsop Launches Unique, Cost-Effective, Single-Use Capsules for Biopharmaceutical Applications
8. BioElectronics Obtains Additional US Patent For Its Unique Pain Devices
9. BioElectronics Unique Pain Relief Product Featured on Leading Healthcare Show in Spain
10. Spine Surgeons Embrace Uniquely Effective Valeo Interbody Fusion Devices As Amedica Announces 10,000 Implantations
11. Pharmaceutical Execs to Gain Manufacturing Insights from Top Aerospace, Automotive and Other Non-Pharma Industries at Unique ISPE Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... , ... Therapeutics, Inc. (PTC) today announced the initiation of an additional ... with nonsense mutation Duchenne/ Becker muscular dystrophy (nmDBMD) who ... is evaluating the best methods for measuring functional abilities in ...
... , VENLO, The Netherlands , Jan. 18 ... by the Lancet Oncology found that testing for high-risk types ... invasive cervical cancer than cytology (Pap testing) alone. The trial used QIAGEN,s ... HC2 HPV DNA Test), which detects the high-risk types of HPV that ...
Cached Medicine Technology:PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 2PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 3PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 4PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 5PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 6Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 2Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 3Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 4Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 5Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 6
(Date:4/16/2014)... 15, 2014 The Translational Genomics Research Institute (TGen) ... Founders Dinner for their support of TGen,s research into ... March 28 in Scottsdale. , Catherine Ivy, Founder and ... TGen,s John S. McCain Leadership Award, named for U.S. ...
(Date:4/16/2014)... While it is well known that fertility treatments are ... that multiples are at elevated risk of premature birth, ... Fertility and Sterility . The article ... reduce the odds of multiple births and prematurity, including ...
(Date:4/15/2014)... a recent analysis by the RECIST Working Group published in ... explored whether a more refined categorization of tumor response or ... in the RECIST database. They found that modeling target ... survival above and beyond that of the other components of ...
(Date:4/14/2014)... Ford Hospital reached a medical milestone April 3, performing ... way to access the heart. , Henry Ford is ... unique procedure called transcaval valve replacement, which accesses the ... Michigan resident Viola Waller, 80, underwent Henry Ford,s first ...
(Date:4/14/2014)... treatment decisions leaves cancer patients feeling more satisfied with ... the experience, researchers from the Perelman School of ... the journal Cancer . , In a study ... MD , an associate professor in the department in ...
Breaking Medicine News(10 mins):Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Can refined categorization improve prediction of patient survival in RECIST 1.1? 2Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Shared decision making during radiation therapy improves patient satisfaction 2Health News:Shared decision making during radiation therapy improves patient satisfaction 3
... Day (Dec 1), India will launch a new scheme to ... Anbumani Ramadoss said here Monday. // ,"On Nov 30, ... treatment for children using paediatric anti-retroviral (ARV) drugs. We have ... four pharmaceutical companies are part of the process," Ramadoss told ...
... the United Kingdom concluded that the UK's National Health ... least// for now. The review was published in the ... series of the Health Technology Assessment Programme, part of ... Kingdom. ,An implantable pump can help heart ...
... indicates future heart problems, according to a study.,This research ... Journal of the American College of Cardiology. ... having a heart attack are at greater risk for ... depression-related screening protocols and treatment strategies. ,Known ...
... a familiar giant. Smokers around the world find it hard ... buy time by assuming that, cutting// down on the number ... latest research disagrees. ,A study published by ‘Tobacco Control’ ... number of cigarettes you smoke or continue to smoke 15 ...
... Pharma Ltd, based in Hyderabad, India, has announced the launch ... treat certain types of lung cancer. A very costly// preparation, ... imported version of the same medication, costs a whopping Rs ... first ever generic version of Pemetrexed, in the global arena. ...
... system has been developed that surpasses mammography in detecting ... had developed the system and the// University has licensed ... to make, use and sell the scanners. The National ... the Development. ,While commenting on the new ...
Cached Medicine News:Health News:Free HIV Treatment to Be Launched for Children 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 3Health News:Depression After Heart Attack Means More Heart Problems 2Health News:Depression After Heart Attack Means More Heart Problems 3Health News:For Smokers Only: is Quitting = Cutting Down?? a 'grave' Issue 2Health News:New Imaging System Surpasses Mammography In Detecting Breast Cancer 2
... From the Pioneer in Digital EEG ... Digital EEG system presents the latest ... the Ceegraph VISION. This innovative system ... remote communications and information management to ...
"Ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Complies with international standards of electrophysiology....
The field of application of the SL 120 Slit Lamp extends from the anterior ocular segment and the vitreous right back to the fundus. It is the ideal configuration for observation, measurement, diagno...
Lens Loading and Folding for Multipiece & Single-Piece ACRYSOF Lens with Standard Forceps...
Medicine Products: